Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...
Repario Unveils New Brand, Expanded Services, Proprietary Technologies and Educational Content Program Fueled by ...
Graphy reinforces its global orthodontic presence at AEEDC, showcasing SMA technology and strengthening strategic ...
The Supreme Court struck down President Donald Trump’s far-reaching global tariffs in a 6-3 decision on Friday, handing him a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results